NCT05895214View on ClinicalTrials.gov

Mesopancreas Study in Pancreatic Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2027

Conditions
PDACPancreatoduodenectomyMargin, ResectionSurgeryLocal Recurrent Tumor
Interventions
PROCEDURE

oncological relevance of the mesopancreas

Invasion status Invasion depth in mm Depth of mesopancreas in mm Treitz fascia intact (histopathological examination)

Trial Locations (1)

Unknown

University Hospital Duesseldorf, Heinrich Heine University, Düsseldorf

All Listed Sponsors
lead

Heinrich-Heine University, Duesseldorf

OTHER

NCT05895214 - Mesopancreas Study in Pancreatic Cancer | Biotech Hunter | Biotech Hunter